Inhibition of Islet Amyloid Polypeptide Fibrillation by Structurally Diverse Phenolic Compounds and Fibril Disaggregation Potential of Rutin and Quercetin.
Abioye RO, Okagu OD, Udenigwe CC.
J Agric Food Chem. 2022 Jan 12;70(1):392-402. doi: 10.1021/acs.jafc.1c06918. Epub 2021 Dec 29.
PMID:34964624
Evaluating the inhibitory potential of natural compound luteolin on human lysozyme fibrillation.
Ali SM, Nabi F, Hisamuddin M, Rizvi I, Ahmad A, Hassan MN, Paul P, Chaari A, Khan RH.
Int J Biol Macromol. 2023 Apr 1;233:123623. doi: 10.1016/j.ijbiomac.2023.123623. Epub 2023 Feb 10.
PMID:36773857
Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation.
Maille B, Lalevée N, Marlinge M, Vahdat J, Mottola G, Degioanni C, De Maria L, Klein V, Thuny F, Franceschi F, Deharo JC, Guieu R, Fromonot J.
Biomedicines. 2022 Nov 17;10(11):2963. doi: 10.3390/biomedicines10112963.
PMID:36428533
TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of alpha-Synuclein, a Parkinson's Disease-Related Protein.
Mohammadi S, Nikkhah M.
Iran J Biotechnol. 2017 Aug 19;15(2):87-94. doi: 10.15171/ijb.1519. eCollection 2017.
PMID:29845055
Atrial Fibrillation: The Science behind Its Defiance.
Czick ME, Shapter CL, Silverman DI.
Aging Dis. 2016 Oct 1;7(5):635-656. doi: 10.14336/AD.2016.0211. eCollection 2016 Oct.
PMID:27699086
Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review.